Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue SUPPL. 1, 2007, Pages

  Matsuyama, Tomomi ^a   Uemura, Masahito ^a   Ishikawa, Masatoshi ^a   Matsumoto, Masanori ^a   Ishizashi, Hiromichi ^a   Kato, Seiji ^a   Morioka, Chie ^a   Fujimoto, Masao ^a   Kojima, Hideyuki ^a   Yoshiji, Hitoshi ^a   Takimura, Chikara ^b   Fujimura, Yoshihiro ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Asuka Hospital   (Japan)

Author keywords

ADAMTS13; Alcoholic Hepatitis; Microcirculatory Disturbance; Multiorgan Failure; Von Willebrand Factor

Indexed keywords

ALBUMIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADAM PROTEINS; ADULT; AGED; ANTIGENS; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 33846291847     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2006.00283.x     Document Type: Conference Paper

References (39)

1. Albornoz L, Alvarez D, Otaso JC, Gadano A, Salviu J, Gerona S, Sorroche P, Villamil A, Mastai R (1999) Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol 30:451-455.
2. Bernardo A, Ball C, Nolasco L, Moake JF, Dong J (2004) Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 104:100-106.
3. Carithers RL Jr., Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC (1989) Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 110:685-690.
4. French SW, Benson NC, Sun PS (1984) Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 4:912-917.
5. Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver diseases. Alcohol Clin Exp Res 23:33S-38S.
6. Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K (2002) Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol 75:25-34.
7. Fukui H, Brauner B, Bode JC, Bode C (1991) Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12:162-169.
8. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578-1584.
9. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89:3097-3103.
10. Goodman ZD, Ishak KG (1982) Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83:786-796.
11. Horn T, Christoffersen P, Henriksen JH (1987) Alcoholic liver injury: defenestration in noncirrhotic livers - a scanning electron microscopic study. 7:77-82.
12. Ishii K, Furudera S, Kumashiro R, Koga Y, Hamada T, Sata M, Abe H, Tanikawa K (1993) Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. Alcohol Alcohol 1B:97-103.
13. 2+ channels in hepatic stellate cells. Biochem Biophys Res Commun 251:533-537.
14. Kavakli K (2002) Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatr Hemat Oncol 19:467-478.
15. Kishi M, Maeyama S, Iwaba A, Ogata S, Koike J, Uchikoshi T (2000) Hepatic veno-occlusive lesions and other histopathological changes of the liver in severe alcoholic hepatitis - a comparative clinicohistopathological study of autopsy cases. Alcohol Clin Exp Res 24: 74S-80S.
16. Langley PG, Hughes RD, Williams R (1985) Increased factor VIII complex in fulminant hepatic failure. Thromb Haemostasis 54:693-696.
17. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS13 gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494.
18. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr., Mezey E, White RI Jr (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193-199.
19. Mak KM, Lieber CS (1984) Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: a scanning electron microscopic study. Hepatology 4:386-491.
20. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E (2001) Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor. Blood 98:2730-2735.
21. Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y (2004) The Japanese experience with thrombotic thrombocytopenic purpurahemolytic uremic syndrome. Semin Hematol 41:68-74.
22. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589-599.
23. Mookerjee RP, Sen S, Davies NA, Hodges SJ, Williams R, Jalan R (2003) Tumor necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 52:1182-1187.
24. Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y (2002) Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion 42:572-580.
25. Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Sac 24: 21-24.
26. Oshita M, Takei Y, Kawano S, Yoshihara H, Hijioka T, Fukui H, Goto M, Masuda E, Nishimura Y, Fusamoto H, Kamada T (1993) Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest 91:1337-1342.
27. Park YD, Yoshioka A, Kawa K, Ishizashi H, Yagi H, Yamamoto Y, Matsumoto M, Fujimura Y (2002) Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant 29:789-794.
28. Plaimauer B, Zimmermann K, Volkel D, Antoine G, Kerschbaumer R, Jenab P, Furlan M, Gerritsen H, Lämmle B, Schwarz HP, Scheiflinger F (2002) Cloning, expression and characterization of the von Willebrand factor-cleaving protease (ADAMTS 13). Blood 100: 3626-3632.
29. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesphageal varices. Br J Surg 60:646-649.
30. Ruggeri ZM (1997) von Willebrand factor. J Clin Invest 100:S41-46.
31. Soejima K, Mimura N, Hirashima M, Maeda H, Takayoshi H, Nakazaki T, Nozaki C (2001) A novel human metalloproteinase synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130:475-480.
32. Takada A, Japanese Study Group for Alcoholic Liver Disease (1993) A new diagnostic criteria of alcoholic liver disease. Acta Hepatol Jpn 34:888-896.
33. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. On behalf of the scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and haemostasis (ISTH). Thromb Haemost 86:1327-1330.
34. Trey C, Burns DG, Saunders SJ (1966) Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 274:473-481.
35. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585-1594.
36. Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto T, Mori T, Wanaka A, Fukui H, Fujimura Y (2005a) Localization of ADAMTS13 to the stellate cells of human liver. Blood 106:922-924.
37. Uemura M, Matsuyama T, Ishikawa M, Fujimoto M, Kojima H, Sakurai S, Ishii I, Toyohara M, Yamazaki M, Yoshiji H, Yamao Y, Matsumoto M, Ishizashi I, Fujimura F, Fukui H (2005b) Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res 29:264S-271S.
38. Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A (1993) Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol 28:77-84.
39. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS 13), metalloproteinase involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41089-41163.